Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
The Lancet: Persistent fossil fuel over-dependence puts health of current and future generations in jeopardy
As countries and health systems continue to grapple with the health, social and economic implications…
The Lancet journals: Over 250 health journals urge world leaders to deliver climate justice for Africa
Over 250 health journals across the world have come together to simultaneously publish an editorial…
Targeting enzyme could alleviate muscle wasting for cancer patients
Targeting a specific enzyme in the muscle could help cancer patients preserve muscle mass and…
Molecular profiling identifies new high-risk subtype of paediatric liver cancer
- ASCO 2022: Follow-up data further support the superior efficacy of cabozantinib in patients with progressive differentiated thyroid cancer
- Researchers discover effective combination immunotherapy for liver cancer
- Preliminary study shows minimally invasive diagnostic biomarker strategy successful in detecting early oesophageal cancer
Trial publishes data on preventing blood clots in cancer patients
The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.